Annual Current Ratio
23.55
+19.72+514.88%
31 March 2024
Summary:
VistaGen Therapeutics annual current ratio is currently 23.55, with the most recent change of +19.72 (+514.88%) on 31 March 2024. During the last 3 years, it has fallen by -1.31 (-5.27%). VTGN annual current ratio is now -5.27% below its all-time high of 24.86, reached on 31 March 2021.VTGN Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
13.29
-4.48-25.21%
30 September 2024
Summary:
VistaGen Therapeutics quarterly current ratio is currently 13.29, with the most recent change of -4.48 (-25.21%) on 30 September 2024. Over the past year, it has dropped by -0.14 (-1.04%). VTGN quarterly current ratio is now -62.27% below its all-time high of 35.22, reached on 31 December 2020.VTGN Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTGN Current Ratio Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +514.9% | -1.0% |
3 y3 years | -5.3% | +9.0% |
5 y5 years | +383.6% | +1065.8% |
VTGN Current Ratio High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -5.3% | +514.9% | -56.8% | +364.7% |
5 y | 5 years | -5.3% | +4031.6% | -62.3% | +2727.7% |
alltime | all time | -5.3% | >+9999.0% | -62.3% | >+9999.0% |
VistaGen Therapeutics Current Ratio History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | 13.29(-25.2%) |
June 2024 | - | 17.77(-24.5%) |
Mar 2024 | 23.55(+514.9%) | 23.55(-23.4%) |
Dec 2023 | - | 30.76(+129.0%) |
Sept 2023 | - | 13.43(+369.6%) |
June 2023 | - | 2.86(-25.3%) |
Mar 2023 | 3.83(-68.9%) | 3.83(-37.0%) |
Dec 2022 | - | 6.08(-0.5%) |
Sept 2022 | - | 6.11(-0.8%) |
June 2022 | - | 6.16(-50.0%) |
Mar 2022 | 12.32(-50.4%) | 12.32(-8.8%) |
Dec 2021 | - | 13.51(+10.8%) |
Sept 2021 | - | 12.19(-23.5%) |
June 2021 | - | 15.93(-35.9%) |
Mar 2021 | 24.86(+4261.4%) | 24.86(-29.4%) |
Dec 2020 | - | 35.22(+627.7%) |
Sept 2020 | - | 4.84(+490.2%) |
June 2020 | - | 0.82(+43.9%) |
Mar 2020 | 0.57(-88.3%) | 0.57(+21.3%) |
Dec 2019 | - | 0.47(-58.8%) |
Sept 2019 | - | 1.14(-57.0%) |
June 2019 | - | 2.65(-45.6%) |
Mar 2019 | 4.87(-35.6%) | 4.87(+34.2%) |
Dec 2018 | - | 3.63(-44.0%) |
Sept 2018 | - | 6.48(+54.7%) |
June 2018 | - | 4.19(-44.6%) |
Mar 2018 | 7.56(+206.1%) | 7.56(-28.2%) |
Dec 2017 | - | 10.53(+749.2%) |
Sept 2017 | - | 1.24(-41.5%) |
June 2017 | - | 2.12(-14.2%) |
Mar 2017 | 2.47 | 2.47(-19.8%) |
Dec 2016 | - | 3.08(-19.8%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2016 | - | 3.84(-28.8%) |
June 2016 | - | 5.39(+1022.9%) |
Mar 2016 | 0.48(+4700.0%) | 0.48(-46.7%) |
Dec 2015 | - | 0.90(+16.9%) |
Sept 2015 | - | 0.77(+57.1%) |
June 2015 | - | 0.49(+4800.0%) |
Mar 2015 | 0.01(0.0%) | 0.01(0.0%) |
Dec 2014 | - | 0.01(-66.7%) |
Sept 2014 | - | 0.03(-66.7%) |
June 2014 | - | 0.09(+800.0%) |
Mar 2014 | 0.01(-96.4%) | 0.01(-50.0%) |
Dec 2013 | - | 0.02(-60.0%) |
Sept 2013 | - | 0.05(-37.5%) |
June 2013 | - | 0.08(-71.4%) |
Mar 2013 | 0.28(+300.0%) | 0.28(+600.0%) |
Dec 2012 | - | 0.04(-63.6%) |
Sept 2012 | - | 0.11(-8.3%) |
June 2012 | - | 0.12(+71.4%) |
Mar 2012 | 0.07(-87.5%) | 0.07(-46.2%) |
Dec 2011 | - | 0.13(+85.7%) |
Sept 2011 | - | 0.07(-75.0%) |
June 2011 | - | 0.28(-69.2%) |
Mar 2011 | - | 0.91(+62.5%) |
Dec 2010 | 0.56(+40.0%) | 0.56(-17.6%) |
Sept 2010 | - | 0.68(-46.5%) |
June 2010 | - | 1.27(+53.0%) |
Mar 2010 | - | 0.83(+107.5%) |
Dec 2009 | 0.40(-95.0%) | 0.40(-64.0%) |
Sept 2009 | - | 1.11(+11.0%) |
June 2009 | - | 1.00(-87.6%) |
Dec 2008 | 8.07 | 8.07(>+9900.0%) |
June 2008 | - | 0.05(-54.5%) |
Mar 2008 | - | 0.11 |
FAQ
- What is VistaGen Therapeutics annual current ratio?
- What is the all time high annual current ratio for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual current ratio year-on-year change?
- What is VistaGen Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly current ratio year-on-year change?
What is VistaGen Therapeutics annual current ratio?
The current annual current ratio of VTGN is 23.55
What is the all time high annual current ratio for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual current ratio is 24.86
What is VistaGen Therapeutics annual current ratio year-on-year change?
Over the past year, VTGN annual current ratio has changed by +19.72 (+514.88%)
What is VistaGen Therapeutics quarterly current ratio?
The current quarterly current ratio of VTGN is 13.29
What is the all time high quarterly current ratio for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly current ratio is 35.22
What is VistaGen Therapeutics quarterly current ratio year-on-year change?
Over the past year, VTGN quarterly current ratio has changed by -0.14 (-1.04%)